Literature DB >> 1435750

Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins.

R Graf1, J Codina, L Birnbaumer.   

Abstract

Pertussis toxin (PTX) ADP-ribosylates alpha subunits of GTP-binding proteins (G proteins) when they are in association with beta gamma dimers, and free alpha subunits are thought not to be substrates under standard assay conditions. We now report the rather unexpected discovery that synthetic peptides encompassing the last 10-20 amino acids of alpha subunits of PTX-sensitive G proteins are substrates for PTX by themselves and in the absence of beta gamma dimers. As determined for G13, the Km of PTX for the 20-amino acid carboxyl-terminal peptide is 10-fold higher than that for the trimeric G protein. Interestingly, PTX ADP-ribosylates the free full length alpha 13 subunit with a Km not different from that of the trimer but with a Vmax that is only 1% of that with which it ADP-ribosylates the trimer. It follows that the primary role of beta gamma dimers in ADP-ribosylation of G proteins is one of increasing the Vmax of the reaction without affecting the Km of the substrate for the toxin. Mutant peptides lacking the ADP-ribose acceptor site act as competitive inhibitors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435750

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Structure-function analyses of a pertussis-like toxin from pathogenic Escherichia coli reveal a distinct mechanism of inhibition of trimeric G-proteins.

Authors:  Dene R Littler; Sheng Y Ang; Danilo G Moriel; Martina Kocan; Oded Kleifeld; Matthew D Johnson; Mai T Tran; Adrienne W Paton; James C Paton; Roger J Summers; Mark A Schembri; Jamie Rossjohn; Travis Beddoe
Journal:  J Biol Chem       Date:  2017-06-29       Impact factor: 5.157

2.  Confocal microscopy study of pertussis toxin and toxoids on CHO-cells.

Authors:  Yajun Tan; Roland A Fleck; Catpagavalli Asokanathan; Chun-Ting Yuen; Dorothy Xing; Shumin Zhang; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

Review 3.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

Review 4.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 5.  Enzymatic and nonenzymatic ADP-ribosylation of cysteine.

Authors:  L J McDonald; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

6.  Studies on G-protein alpha.betagamma heterotrimer formation reveal a putative S-prenyl-binding site in the alpha subunit.

Authors:  Alexander Dietrich; Alexander Scheer; Daria Illenberger; Yoel Kloog; Yoav I Henis; Peter Gierschik
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

7.  A mutational analysis of residues in cholera toxin A1 necessary for interaction with its substrate, the stimulatory G protein Gsα.

Authors:  Michael G Jobling; Lisa F Gotow; Zhijie Yang; Randall K Holmes
Journal:  Toxins (Basel)       Date:  2015-03-18       Impact factor: 4.546

Review 8.  In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity.

Authors:  Marieke Esther Hoonakker
Journal:  Toxins (Basel)       Date:  2021-08-12       Impact factor: 4.546

9.  iGIST-A Kinetic Bioassay for Pertussis Toxin Based on Its Effect on Inhibitory GPCR Signaling.

Authors:  Valeriy M Paramonov; Cecilia Sahlgren; Adolfo Rivero-Müller; Arto T Pulliainen
Journal:  ACS Sens       Date:  2020-11-04       Impact factor: 7.711

10.  Single-Peptide TR-FRET Detection Platform for Cysteine-Specific Post-Translational Modifications.

Authors:  Ville Eskonen; Natalia Tong-Ochoa; Leena Mattsson; Moona Miettinen; Mika Lastusaari; Arto T Pulliainen; Kari Kopra; Harri Härmä
Journal:  Anal Chem       Date:  2020-09-16       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.